These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19641653)

  • 41. T cells expressing the gamma delta T-cell receptor potentiate coxsackievirus B3-induced myocarditis.
    Huber SA; Moraska A; Choate M
    J Virol; 1992 Nov; 66(11):6541-6. PubMed ID: 1328680
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The analysis of T cell receptor Vbeta gene usage of cytolytic T-lymphocytes in coxsackievirus B3-induced myocarditis].
    Wang YB; Hua YM; Shi XQ; Yang Y; Wei DP
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):80-3. PubMed ID: 16468649
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nitric oxide and Coxsackievirus B3 myocarditis: differential expression of inducible nitric oxide synthase in mouse heart after infection with virulent or attenuated virus.
    Bevan AL; Zhang H; Li Y; Archard LC
    J Med Virol; 2001 Jun; 64(2):175-82. PubMed ID: 11360250
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vivo significance of T cells in the development of Coxsackievirus B3 myocarditis in mice. Immature but antigen-specific T cells aggravate cardiac injury.
    Kishimoto C; Abelmann WH
    Circ Res; 1990 Sep; 67(3):589-98. PubMed ID: 1697791
    [TBL] [Abstract][Full Text] [Related]  

  • 45. AIM2 co-immunization favors specific multifunctional CD8(+) T cell induction and ameliorates coxsackievirus B3-induced chronic myocarditis.
    Chai D; Yue Y; Xu W; Dong C; Xiong S
    Antiviral Res; 2015 Jul; 119():68-77. PubMed ID: 25956163
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Monoclonal antibody therapy for prevention of acute coxsackievirus B3 myocarditis in mice.
    Kishimoto C; Abelmann WH
    Circulation; 1989 Jun; 79(6):1300-8. PubMed ID: 2541943
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of coxsackievirus B3 ts mutants for induction of myocarditis in a murine model.
    Trousdale MD; Paque RE; Nealon T; Gauntt CJ
    Infect Immun; 1979 Feb; 23(2):486-95. PubMed ID: 217832
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Myeloid-Derived Suppressor Cells Restrain Natural Killer Cell Activity in Acute Coxsackievirus B3-Induced Myocarditis.
    Müller I; Janson L; Sauter M; Pappritz K; Linthout SV; Tschöpe C; Klingel K
    Viruses; 2021 May; 13(5):. PubMed ID: 34065891
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pathogenic Role of the Damage-Associated Molecular Patterns S100A8 and S100A9 in Coxsackievirus B3-Induced Myocarditis.
    Müller I; Vogl T; Pappritz K; Miteva K; Savvatis K; Rohde D; Most P; Lassner D; Pieske B; Kühl U; Van Linthout S; Tschöpe C
    Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29158436
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Roles of programmed death-1 (PD-1)/PD-1 ligands pathway in the development of murine acute myocarditis caused by coxsackievirus B3.
    Seko Y; Yagita H; Okumura K; Azuma M; Nagai R
    Cardiovasc Res; 2007 Jul; 75(1):158-67. PubMed ID: 17434153
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In situ immune autoradiographic identification of cells in heart tissues of mice with coxsackievirus B3-induced myocarditis.
    Godeny EK; Gauntt CJ
    Am J Pathol; 1987 Nov; 129(2):267-76. PubMed ID: 2823612
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Coxsackievirus B3 induces T regulatory cells, which inhibit cardiomyopathy in tumor necrosis factor-alpha transgenic mice.
    Huber SA; Feldman AM; Sartini D
    Circ Res; 2006 Nov; 99(10):1109-16. PubMed ID: 17038643
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential macrophage polarization in male and female BALB/c mice infected with coxsackievirus B3 defines susceptibility to viral myocarditis.
    Li K; Xu W; Guo Q; Jiang Z; Wang P; Yue Y; Xiong S
    Circ Res; 2009 Aug; 105(4):353-64. PubMed ID: 19608981
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of granulocyte colony-stimulating factor upon coxsackievirus B3 myocarditis in mice.
    Hiraoka Y; Kishimoto C; Takada H; Suzaki N; Shiraki K
    Eur Heart J; 1995 Dec; 16(12):1900-6. PubMed ID: 8682024
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The outcome of coxsackievirus B3-(CVB3-) induced myocarditis is influenced by the cellular immune status.
    Leipner C; Grün K; Borchers M; Stelzner A
    Herz; 2000 May; 25(3):245-8. PubMed ID: 10904846
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pathogenesis of coxsackievirus B3-induced myocarditis: role of macrophage migration inhibitory factor.
    Yu XH; Li SJ; Chen RZ; Yang YZ; Zhang P
    Chin Med J (Engl); 2012 Jan; 125(1):50-5. PubMed ID: 22340465
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Coxsackievirus-induced myocarditis is dependent on distinct immunopathogenic responses in different strains of mice.
    Huber SA
    Lab Invest; 1997 May; 76(5):691-701. PubMed ID: 9166288
    [TBL] [Abstract][Full Text] [Related]  

  • 58. V gamma 1+ T cells suppress and V gamma 4+ T cells promote susceptibility to coxsackievirus B3-induced myocarditis in mice.
    Huber SA; Graveline D; Newell MK; Born WK; O'Brien RL
    J Immunol; 2000 Oct; 165(8):4174-81. PubMed ID: 11035049
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of T lymphocytes in the pathogenesis of Coxsackie virus B3 heart disease.
    Hashimoto I; Tatsumi M; Nakagawa M
    Br J Exp Pathol; 1983 Oct; 64(5):497-504. PubMed ID: 6315043
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytokine and murine coxsackievirus B3 myocarditis. Interleukin-2 suppressed myocarditis in the acute stage but enhanced the condition in the subsequent stage.
    Kishimoto C; Kuroki Y; Hiraoka Y; Ochiai H; Kurokawa M; Sasayama S
    Circulation; 1994 Jun; 89(6):2836-42. PubMed ID: 8205699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.